Latest Listings And Ipos News

Clime Investment Management has reported a return to profitability in the December half, proposing an interim dividend and unveiling strategic initiatives to drive future growth.

VanEck Investments Limited has outlined the dividend timetable for its suite of Australian and global bond ETFs, providing investors with critical dates for dividend entitlements and reinvestment options.

African Gold Ltd. has temporarily paused trading of its securities, signaling a potentially significant update on the horizon. Investors await clarity on what this development might mean for the gold miner’s future.

Southern Cross Gold Ltd has officially become a wholly owned subsidiary of Southern Cross Gold Consolidated Ltd following a scheme of arrangement, with shareholders receiving new securities and the company set for ASX delisting.

Arrow Minerals Ltd has temporarily paused trading of its securities, signaling an imminent announcement that could influence its market position.

Southern Cross Gold Consolidated Ltd has completed its acquisition of Southern Cross Gold Ltd, issuing over 125 million shares and announcing key board changes. The move positions the company to advance the high-potential Sunday Creek Gold-Antimony Project amid a strengthened leadership team.

Barton Gold Holdings reports a robust December quarter marked by a $5 million gold sale, extensive drilling at Tunkillia and Tarcoola projects, and a strong cash position heading into 2025.

DeSoto Resources has secured a strategic manganese project in Brazil and received pioneering drilling approvals in Australia's Northern Territory, setting the stage for significant exploration activity in 2025.

Great Western Exploration Limited reported a $191,000 net cash outflow from operations in the December quarter but bolstered its cash reserves to $4.74 million through a $3.6 million capital raise, maintaining a solid financial footing for ongoing exploration.

Raptis Group Limited reported a positive net cash inflow from operating activities of $54,509 for the quarter ended December 31, 2024, ending with $303,102 in cash and equivalents. The company recorded no investing or financing cash flows during the period.

RLF AgTech Ltd has retracted previously announced field trial results due to ASX compliance issues, while simultaneously reporting significant debt reduction and ongoing equity raising efforts to support its expanding Australian and Chinese operations.

InhaleRx has locked in a $38.5 million funding deal with Clendon Biotech Capital, enabling expanded Phase 2 trials for its inhaled breakthrough cancer pain and panic disorder treatments. The company also filed a key international patent, positioning itself for a faster path to FDA approval.